PCOD

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Searching Images

polycystic ovary syndrome PCOS ultrasound pathology

Reading File
I now have comprehensive content. Here's a thorough overview of PCOS/PCOD:

Polycystic Ovary Syndrome (PCOS / PCOD)

PCOD (Polycystic Ovarian Disease) is an older, synonymous term for PCOS (Polycystic Ovary Syndrome) — now the preferred clinical designation.

Definition & Epidemiology

PCOS is the most common endocrine disorder in women of reproductive age, affecting 5–10% of women worldwide. It is the leading cause of:
  • Hyperandrogenism (HA)
  • Hirsutism
  • Anovulatory infertility
First described in 1935 by Stein and Leventhal as a triad of amenorrhea, bilateral polycystic ovaries, and obesity. It is a complex, polygenic/multifactorial disorder with significant reproductive, metabolic, and cardiovascular consequences.
Berek & Novak's Gynecology, p. 1919

Diagnostic Criteria

Rotterdam Criteria (2003) — 2 out of 3 required (after exclusion of other causes):

CriterionDescription
1. Oligo/anovulationIrregular or absent menstrual cycles
2. HyperandrogenismClinical (hirsutism, acne, alopecia) and/or biochemical (elevated androgens)
3. Polycystic ovary morphology≥12 follicles 2–9 mm diameter, or ovarian volume >10 mL on ultrasound
Diagnosis requires exclusion of: congenital adrenal hyperplasia (CAH), androgen-secreting tumors, Cushing syndrome, hyperprolactinemia, thyroid disease.
4 Rotterdam Phenotypes:
  1. HA + ovarian dysfunction + PCO morphology
  2. HA + ovarian dysfunction
  3. HA + PCO morphology
  4. Ovarian dysfunction + PCO morphology
Berek & Novak's Gynecology, p. 1919–1920

Ultrasound: "String of Pearls" Sign

The classic sonographic finding — multiple small follicles arranged peripherally around an echogenic stroma:
PCOS ultrasound - string of pearls sign
Bilateral polycystic ovaries on ultrasound

Pathophysiology

Hormonal Abnormalities

  • ↑ LH pulse frequency (due to increased GnRH pulse frequency) → elevated LH : FSH ratio
  • FSH remains normal/low due to negative feedback from elevated estrogen and inhibin
  • Elevated androgens (testosterone, DHEA-S): from both ovarian theca cells and adrenal cortex
  • Mild hyperprolactinemia in ~25% of cases

Insulin Resistance (IR)

  • A key pathophysiological mechanism in most women with PCOS
  • Compensatory hyperinsulinemia stimulates ovarian androgen production
  • IR is present even in lean women with PCOS

Steroidogenesis Defect

  • Theca cells show intrinsic upregulation of CYP11A, CYP17, 3β-HSD genes → excess testosterone, 17-OH progesterone, and progesterone
Berek & Novak's Gynecology, p. 1926

Clinical Features

FeatureDetails
Menstrual irregularitiesOligomenorrhea, amenorrhea, or irregular cycles from menarche
HirsutismMost common sign of HA; male-pattern hair growth
Acne & oily skinAndrogen-driven
AlopeciaAndrogenic pattern
ObesityPresent in many; worsens phenotype
InfertilityAnovulatory; most common cause in developed countries
Acanthosis nigricansMarker of IR

Associated Long-Term Risks

SystemRisk
MetabolicType 2 diabetes, impaired glucose tolerance, dyslipidemia, metabolic syndrome
CardiovascularHypertension, atherosclerosis (due to hypercholesterolemia + IR)
ReproductiveMiscarriage, gestational diabetes, preeclampsia, preterm birth
OncologicEndometrial cancer (due to unopposed estrogen from anovulation)
PsychologicalDepression, anxiety

Management

Lifestyle (First-line for all overweight/obese women)

  • Weight loss of 5–10% restores ovulation, reduces androgens, improves insulin sensitivity
  • Reduced-calorie diet (<30% fat), ↑ fiber, low glycemic index foods
  • Structured exercise >30 min/day

Not Seeking Pregnancy

GoalTreatment
Menstrual regulation & HACombined oral contraceptive pill (COCP) — lowers androgens via ↑ SHBG; first-line
Inadequate response to COCP (>6 months)Add antiandrogens: spironolactone or flutamide
Endometrial protectionProgestins (medroxyprogesterone 10 mg, or progesterone 200 mg × 10–14 days, every ≥3 months) or levonorgestrel IUD
Cardiometabolic riskMetformin (especially in overweight/obese)

Seeking Pregnancy (Ovulation Induction)

  1. Letrozole (aromatase inhibitor) — first-line
  2. Clomiphene citrate (± metformin)
  3. Injectable gonadotropins — under specialist supervision (risk of ovarian hyperstimulation syndrome)
  4. Laparoscopic ovarian drilling — surgical option for clomiphene-resistant cases
Metformin alone is not recommended for endometrial protection, hyperandrogenism, infertility, or prevention of gestational diabetes.
Harrison's Principles of Internal Medicine 22E, p. 3179; Berek & Novak's Gynecology, p. 1930

Screening at Diagnosis

  • Obesity / BMI
  • Blood pressure
  • Fasting glucose / HbA1c / oral glucose tolerance test
  • Fasting lipid profile (if overweight)
  • Depression and anxiety screening

Summary

PCOS is a heterogeneous syndrome — not every woman presents the same way. The Rotterdam criteria allow for 4 phenotypes. Management must be tailored to the patient's primary concern: menstrual regulation, hyperandrogenism, fertility, or metabolic risk.
This is a shared conversation. Sign in to Orris to start your own chat.